Maria Yasnot-Acosta

Prof. Dr. Maria Yasnot-Acosta

Universidad de Córdoba
orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 June 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
HTHaruka Toda
Haruka Toda
MDMiriam Diaz-Varela
Miriam Diaz-Varela
JSJoan Segui-Barber
Joan Segui-Barber
WRWanlapa Roobsoong
Wanlapa Roobsoong
BBBarbara Baro
Barbara Baro
HPHernando Del Portillo
Hernando Del Portillo
Plasmodium vivax is the most widely distributed human malaria parasite. Previous studies have shown that circulating microparticles during P. vivax acute attacks are indirectly associated with severity. Extracellular vesicles (EVs) are therefore major components of circulating plasma holding insights into pathological processes. Here, we demonstrate that plasma-derived EVs from Plasmodium vivax patients (PvEVs) are preferentially uptaken by human spleen fibroblasts (hSFs) as compared to the uptake of EVs from healthy individuals. Moreover, this uptake induces specific upregulation of ICAM-1 associated with the translocation of NF-kB to the nucleus. After this uptake, P. vivax-infected reticulocytes obtained from patients show specific adhesion properties to hSFs, reversed by inhibiting NF-kB translocation to the nucleus. Together, these data provide physiological EV-based insights into the mechanisms of human malaria pathology and support the existence of P. vivax-adherent parasite subpopulations in the microvasculature of the human spleen.

14 April 2022 in Wellcome Open Research
Verified
Journal Article
Open access
PDF file
MNMalaria G E N
Malaria G E N
IAIshag Adam
Ishag Adam
SAShafiul Alam
Shafiul Alam
SASisay Alemu
Sisay Alemu
CAChanaki Amaratunga
Chanaki Amaratunga
DYDaniel Yilma
Daniel Yilma
This report describes the MalariaGEN Pv4 dataset, a new release of curated genome variation data on 1,895 samples of Plasmodium vivax collected at 88 worldwide locations between 2001 and 2017. It includes 1,370 new samples contributed by MalariaGEN and VivaxGEN partner studies in addition to previously published samples from these and other sources. We provide genotype calls at over 4.5 million variable positions including over 3 million single nucleotide polymorphisms (SNPs), as well as short indels and tandem duplications. This enlarged dataset highlights major compartments of parasite population structure, with clear differentiation between Africa, Latin America, Oceania, Western Asia and different parts of Southeast Asia. Each sample has been classified for drug resistance to sulfadoxine, pyrimethamine and mefloquine based on known markers at the dhfr, dhps and mdr1 loci. The prevalence of all of these resistance markers was much higher in Southeast Asia and Oceania than elsewhere. This open resource of analysis-ready genome variation data from the MalariaGEN and VivaxGEN networks is driven by our collective goal to advance research into the complex biology of P. vivax and to accelerate genomic surveillance for malaria control and elimination.

1 November 2005 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Closed access
MAMyriam Arévalo-Herrera
Myriam Arévalo-Herrera
YSYezid Solarte
Yezid Solarte
Maria Yasnot-AcostaMaria Yasnot-Acosta
Maria Yasnot-Acosta
ACAngélica Castellanos
Angélica Castellanos
ARAdriana Rincón
Adriana Rincón
SHSócrates Herrera
Sócrates Herrera
Aotus monkeys were used to determine the immunogenicity of Pvs25 protein expressed in the zygote/ookinete surface. Animals were immunized in three times with 100 μg of Pvs25 formulated in Montanide ISA-720. Antibodies to Pvs25 detected by an enzyme-linked immunosorbent assay appeared by day 30 after the first immunization, with a peak of antibodies levels on day 150. These antibodies were still detectable on day 300. Plasma samples on day 150 from experimental group were able to completely block the development of the parasite in Anopheles albimanus mosquitoes artificially fed with human isolates of Plasmodium vivax. Immunized Aotus monkeys were infected with blood forms of the P. vivax Salvador I strain and no boosting effect of blood infection on titers of antibodies to Pvs25 was observed despite the presence of infective gametocytes. In conclusion, Pvs25 protein formulated in Montanide ISA-720 induces efficient and long-lasting transmission-blocking antibodies that cannot be boosted by parasite infection.

1 November 2005 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Closed access
MAMyriam Arévalo-Herrera
Myriam Arévalo-Herrera
YSYezid Solarte
Yezid Solarte
FZFelipe Zamora
Felipe Zamora
Fabian MendezFabian Mendez
Fabian Mendez
Maria Yasnot-AcostaMaria Yasnot-Acosta
Maria Yasnot-Acosta
SHSócrates Herrera
Sócrates Herrera
Plasmodium vivax transmission-blocking activity was assessed in sera from acutely infected patients from a malaria-endemic area in Colombia. We measured reduction in the number of oocysts that developed in the midguts of Anopheles albimanus mosquitoes artificially fed with blood from these patients. Of 88 mosquito batches that developed infections when parasites were mixed with normal AB human serum, one-third (36.4%) showed full transmission-blocking activity (≥ 90% inhibition) when mixed with autologous sera, 29.6% showed partial activity (50–89%), 17.0% did not block transmission (0–50%), and 17% did not enhance transmission. Transmission-blocking activity correlated with antibody titer by an immunofluorescent antibody test and decreased with the serial dilution of the sera. This activity disappeared at a 1:4 dilution in most sera tested. Afro-Colombian individuals showed lower activity than other ethnic groups and febrile patients produced stronger inhibition than those without fever.

20 July 2020 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
Juan Rivera-CorreaJuan Rivera-Correa
Juan Rivera-Correa
Maria Yasnot-AcostaMaria Yasnot-Acosta
Maria Yasnot-Acosta
NTNubia Catalina Tovar
Nubia Catalina Tovar
MVMaría Camila Velasco-Pareja
María Camila Velasco-Pareja
AEAlice Easton
Alice Easton
ARAna Rodriguez
Ana Rodriguez
Malaria caused by Plasmodium vivax is a highly prevalent infection world-wide, that was previously considered mild, but complications such as anemia have been highly reported in the past years. In mice models of malaria, anti-phosphatidylserine (anti-PS) autoantibodies, produced by atypical B-cells, bind to uninfected erythrocytes and contribute to anemia. In human patients with P. falciparum malaria, the levels of anti-PS, atypical B-cells and anemia are strongly correlated to each other. In this study, we focused on assessing the relationship between autoantibodies, different B-cell populations and hemoglobin levels in two different cohorts of P. vivax patients from Colombia, South America. In a first longitudinal cohort, our results show a strong inverse correlation between different IgG autoantibodies tested (anti-PS, anti-DNA and anti-erythrocyte) and atypical memory B-cells (atMBCs) with hemoglobin in both P. vivax and P. falciparum patients over time. In a second cross-sectional cohort, we observed a stronger relation between hemoglobin levels, atMBCs and autoantibodies in complicated P. vivax patients compared to uncomplicated ones. Altogether, these data constitute the first evidence of autoimmunity associating with anemia and complicated P. vivax infections, suggesting a role for its etiology through the expansion of autoantibody-secreting atMBCs. Malaria is one of the top global infections causing high mortality and morbidity every year. Plasmodium vivax is the most prevalent malarial infection, particularly in the region of the Americas. Complications associated with P. vivax, such as anemia, are a growing reported phenomenon, but the mechanisms leading to them are poorly understood. Here, we report the first evidence of autoantibodies and Atypical Memory B-cells correlating with anemia in two different cohorts of P. vivax patients, particularly during complicated infections. These findings point to Atypical Memory B-cells as key pathological players, possibly through the secretion of autoantibodies, and attributes a role for autoimmunity in mediating complications during P. vivax infections.

27 October 2020 in mBio
Verified
Journal Article
Closed access
PDF file
AEAlice V. Easton
Alice V. Easton
MRMayra Raciny-Aleman
Mayra Raciny-Aleman
VLVictor Liu
Victor Liu
ERErica Ruan
Erica Ruan
CMChristian Marier
Christian Marier
PLP’nG Loke
P’nG Loke
Plasmodium (malaria) and helminth parasite coinfections are frequent, and both infections can be affected by the host gut microbiota. However, the relationship between coinfection and the gut microbiota is unclear. By performing comprehensive analyses on blood/stool samples from 130 individuals in Colombia, we found that the gut microbiota may have a stronger relationship with the number of P. vivax (malaria) parasites than with the number of helminth parasites infecting a host. Microbiota analysis identified more predictors of the P. vivax parasite burden, whereas analysis of blood samples identified predictors of the helminth parasite burden. These results were unexpected, because we expected each parasite to be associated with greater differences in its biological niche (blood for P. vivax and the intestine for helminths). Instead, we find that bacterial taxa were the strongest predictors of P. vivax parasitemia levels, while circulating TGF-β levels were the strongest predictor of helminth parasite burdens.